Human papillomavirus genotype distribution in lowgrade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: To investigate the distribution of human papillomavirus (HPV) genotypes in low-grade squamous intraepithelial lesion (LSIL) cytology and the immediate risk of cervical intraepithelial neoplasia grade 2 or higher (CIN2+) lesions. Methods: This prospective cross-sectional study enrolled women aged ≥21 years that were diagnosed with LSIL cytology at Siriraj Hospital (Bangkok, Thailand) during 2017-2019. Anyplex II HPV testing was performed to detect 14 high-risk HPV cases prior to colposcopy-directed biopsy. Results: In total, 318 patients were included in the final analysis. Of those, 24 (7.5%), 241 (75.8%), 53 (16.7%) were aged 21- 25 years, 25-50 years, and ≥50 years, respectively. Eighty-two patients (25.8%) had abnormal screening results within the previous 5 years. High-risk HPV infection was found in 188 patients (59.1%) with 127 (39.9%) having single and 61 (19.2%) having multiple infections. The five most common HPV genotypes were HPV 66 (18.6%), HPV51 (9.7%), HPV58 (9.4%), HPV16 (9.1%), and HPV56 (8.2%). The immediate risk of CIN2+ was 6% in LSIL, regardless of the HPV status, 8% in high-risk HPV-positive LSIL, and 3.1% in high-risk HPV-negative LSIL. When using 6% as the threshold risk for colposcopy, performing reflex HPV testing in LSIL cytology can decrease the number of colposcopies by 40.9%, with an area under the receiver operating characteristic curve of 0.6 (95% confidence interval, 0.5-0.7). Conclusion: The study findings support the idea that geographic variations affect the HPV genotype. Reflex HPV testing may decrease the number of colposcopies in cytology-based screening regions with a high prevalence of low-carcinogenic HPV.
Abstract
Objective: To investigate the distribution of human papillomavirus (HPV) genotypes in low-grade squamous intraepithelial lesion (LSIL) cytology and the immediate risk of cervical intraepithelial neoplasia grade 2 or higher (CIN2+) lesions. Methods: This prospective cross-sectional study enrolled women aged ≥21 years that were diagnosed with LSIL cytology at Siriraj Hospital (Bangkok, Thailand) during 2017-2019. Anyplex II HPV testing was performed to detect 14 high-risk HPV cases prior to colposcopy-directed biopsy. Results: In total, 318 patients were included in the final analysis. Of those, 24 (7.5%), 241 (75.8%), 53 (16.7%) were aged 21- 25 years, 25-50 years, and ≥50 years, respectively. Eighty-two patients (25.8%) had abnormal screening results within the previous 5 years. High-risk HPV infection was found in 188 patients (59.1%) with 127 (39.9%) having single and 61 (19.2%) having multiple infections. The five most common HPV genotypes were HPV 66 (18.6%), HPV51 (9.7%), HPV58 (9.4%), HPV16 (9.1%), and HPV56 (8.2%). The immediate risk of CIN2+ was 6% in LSIL, regardless of the HPV status, 8% in high-risk HPV-positive LSIL, and 3.1% in high-risk HPV-negative LSIL. When using 6% as the threshold risk for colposcopy, performing reflex HPV testing in LSIL cytology can decrease the number of colposcopies by 40.9%, with an area under the receiver operating characteristic curve of 0.6 (95% confidence interval, 0.5-0.7). Conclusion: The study findings support the idea that geographic variations affect the HPV genotype. Reflex HPV testing may decrease the number of colposcopies in cytology-based screening regions with a high prevalence of low-carcinogenic HPV.
참고문헌 (38)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Vaccarella S, "Worldwide trends in cervical cancer incidence : impact of screening against changes in disease risk factors", Eur J Cancer, 49, pp.3262~3273 (2013)
- 하형인, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry", Obstetrics & Gynecology Science, 64(5), pp.444~453 (2021), 대한산부인과학회
- Safaeian M, "Cervical cancer prevention--cervical screening : science in evolution", Obstet Gynecol Clin North Am, 34, pp.739~760 (2007)
- Schiffman M, "Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting", N Engl J Med, 369, pp.2324~2331 (2013)
- Wright TC, "Primary cervical cancer screening with human papillomavirus : end of study results from the ATHENA study using HPV as the first-line screening test", Gynecol Oncol, 136, pp.189~197 (2015)
- 공태욱, "High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology", Obstetrics & Gynecology Science, 63(2), pp.107~107 (2020), 대한산부인과학회[DOI]
- Fontham ETH, "Cervical cancer screening for individuals at average risk : 2020 guideline update from the American Cancer Society", CA Cancer J Clin, 70, pp.321~346 (2020)
- Egemen D, "Risk estimates supporting the 2019ASCCP risk-based management consensus guidelines", J Low Genit Tract Dis, 24, pp.132~143 (2020)
- Perkins RB, "2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors", J Low Genit Tract Dis, 24, pp.102~131 (2020)
- Schiffman M, "An introduction to the 2019 ASCCP risk-based management consensus guidelines", J Low Genit Tract Dis, 24, pp.87~89 (2020)
- ASCUS-LSIL Traige Study(ALTS)Group, "Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance", Am J Obstet Gynecol, 188, pp.1383~1392 (2003)
- Solomon D, "Comparison of three management strategies for patients with atypical squamous cells of undetermined significance : baseline results from a randomized trial", J Natl Cancer Inst, 93, pp.293~299 (2001)
- Schiffman M, "Findings to date from the ASCUS-LSIL triage study(ALTS)", Arch Pathol Lab Med, 127, pp.946~949 (2003)
- Safaeian M, "Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance", Obstet Gynecol, 109, pp.1325~1331 (2007)
- The Atypical Squamous Cells of Undetermined Significance, "Low-Grade Squamous Intraepithelial Lesions Triage Study(ALTS)Group", Human papillomavirus testing for triage of women with cytologic evidence of lowgrade squamous intraepithelial lesions : baseline data from a randomized trial, 2000, pp.92, 397~402
- ASCUS-LSIL Traige Study(ALTS)Group, "A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations", Am J Obstet Gynecol, 188, pp.1393~1400 (2003)
- Darragh TM, "The lower anogenital squamous terminology standardization project for HPV-associated lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology", J Low Genit Tract Dis, 16, pp.205~242 (2012)
- Massad LS, "2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors", J Low Genit Tract Dis, 17(5 Suppl 1), pp.S1~S27 (2013)
- Kelly RS, "HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology : results from the sentinel sites study", Br J Cancer, 105, pp.983~988 (2011)
- Silveira FA, "HPV DNA genotyping and methylation of gene p16 INK4A in cervical LSIL", Exp Mol Pathol, 98, pp.308~311 (2015)
- Katki HA, "Five-year risks of CIN 2+ and CIN 3+among women with HPV-positive and HPV-negative LSIL pap results", J Low Genit Tract Dis, 17(5 Suppl 1), pp.S43~9 (2013)
- Katki HA, "Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines", J Low Genit Tract Dis, 17(5 Suppl 1), pp.S28~S35 (2013)
- Wang J, "Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China", Hum Vaccin Immunother, 15, pp.1889~1896 (2019)
- Hwang HS, "Distribution and prevalence of human papillomavirus genotypes in routine Pap smear of 2, 470 Korean women determined by DNA chip", Cancer Epidemiol Biomarkers Prev, 13, pp.2153~2156 (2004)
- Ekalaksananan T, "Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia(CIN II-III)in Thai patients with low-grade cytological abnormalities", Asian Pac J Cancer Prev, 12, pp.1777~1783 (2011)
- Khunamornpong S, "Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities(ASC-US", LSIL)in Northern Thailand, 2014, pp.15, 10961~10966
- Siriaunkgul S, "Population-based cervical cancer screening using high-risk HPV DNA test and liquid-based cytology in northern Thailand", Asian Pac J Cancer Prev, 15, pp.6837~6842 (2014)
- Phoolcharoen N, "A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand", Gynecol Oncol Rep, 21, pp.73~77 (2017)
- Laowahutanont P, "Prevalence of high risk human papillomavirus infection with different cervical cytological features among women undergoing health examination at the National Cancer Institute, Thailand", Asian Pac J Cancer Prev, 15, pp.5879~5882 (2014)
- Wright TC Jr, "Risk detection for high-grade cervical disease using onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology", Gynecol Oncol, 154, pp.360~367 (2019)
- Bruni L, "Cervical human papillomavirus prevalence in 5 continents : meta-analysis of 1 million women with normal cytological findings", J Infect Dis, 202, pp.1789~1799 (2010)
- Santos AL, "Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or lowgrade squamous intraepithelial lesion", Sao Paulo Med J, 121, pp.238~243 (2003)
- Massad LS, "Using patient history to predict high-grade cervical dysplasia and cancer in women with borderline cervical cytologic results", J Low Genit Tract Dis, 8, pp.207~211 (2004)
- Khuakoonratt N, "Prevalence of high grade squamous intraepithelial lesion(HSIL)and invasive cervical cancer in patients with low grade squamous intraepithelial lesion(LSIL)at cervical pap smear", Asian Pac J Cancer Prev, 9, pp.253~257 (2008)
- Carreon JD, "CIN2 is a much less reproducible and less valid diagnosis than CIN3 : results from a histological review of population-based cervical samples", Int J Gynecol Pathol, 26, pp.441~446 (2007)
- Tainio K, "Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance : systematic review and meta-analysis", BMJ, 360, pp.k499~ (2018)
- Castle PE, "Relationships of p16immunohistochemistry and other biomarkers with diagnoses of cervical abnormalities : implications for LAST terminology", Arch Pathol Lab Med, 144, pp.725~734 (2020)